Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Albert David Limited

Market Cap 3.35B 35.5M 30.96M 28.67M 26.84M 50.34M 50.64M 340M 132M 1.65B 133M 130M 5.73B P/E 2024
8.14x
P/E 2025 26.9x
Enterprise Value 1.04B 10.99M 9.58M 8.87M 8.31M 15.58M 15.67M 105M 40.79M 510M 41.24M 40.36M 1.77B EV / Sales 2024
0.92x
EV / Sales 2025 0.67x
Free-Float
35.96%
Yield 2024
1.07%
Yield 2025 0.62%
1 day-0.11%
1 week-1.99%
Current month+0.38%
1 month-0.74%
3 months+5.93%
6 months-4.36%
Current year-3.46%
1 week 701
Extreme 701
737.95
1 month 683.5
Extreme 683.5
737.95
Current year 579.9
Extreme 579.9
819.6
1 year 579.9
Extreme 579.9
957.5
3 years 579.9
Extreme 579.9
1,753.95
5 years 472.8
Extreme 472.8
1,753.95
10 years 263
Extreme 263
1,753.95
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO - 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 14/11/2024
Chairman 72 30/12/2009
Director/Board Member 68 31/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%-1.99% - - 43.26M
+0.74%+1.69%+11.57%+83.50% 46.74B
-2.91%+3.09%+49.98%+91.04% 34.33B
-0.27%-2.71%-8.91%+33.68% 11.57B
-0.34%-3.07%+12.71%+93.23% 11.42B
-0.57%+0.96%+38.89%+128.26% 9.09B
+0.43%-1.68%+14.22%+40.48% 6.98B
-1.23%+1.65%+43.80%-18.26% 6.55B
+2.77%+1.83%+35.04%+245.66% 6.62B
+0.73%-2.94%-36.14%-5.18% 5B
Average -0.08%+0.08%+17.91%+76.93% 15.37B
Weighted average by Cap. -0.44%+0.99%+22.34%+82.51%

Financials

2024 2025
Net sales 3.62B 38.41M 33.49M 31.02M 29.04M 54.46M 54.79M 368M 143M 1.78B 144M 141M 6.19B 3.46B 36.64M 31.95M 29.59M 27.7M 51.95M 52.27M 351M 136M 1.7B 138M 135M 5.91B
Net income 754M 7.99M 6.97M 6.45M 6.04M 11.33M 11.4M 76.57M 29.68M 371M 30M 29.36M 1.29B 172M 1.82M 1.59M 1.47M 1.38M 2.58M 2.6M 17.46M 6.77M 84.66M 6.84M 6.7M 294M
Net Debt -2.82B -29.88M -26.05M -24.13M -22.58M -42.36M -42.61M -286M -111M -1.39B -112M -110M -4.82B -2.31B -24.52M -21.38M -19.8M -18.53M -34.76M -34.97M -235M -91.03M -1.14B -92.03M -90.06M -3.95B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,805
Date Price Change Volume
19/06/26 711.15 -0.11% 1,513
18/06/26 711.90 +0.68% 1,621
17/06/26 707.10 -1.08% 2,253
16/06/26 714.85 -0.90% 1,532
15/06/26 721.35 -0.59% 4,188
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!